Home LiteratureArticle Details
PMID: 11130552 Published · ppublish English Comment Letter

Safety of insulin glargine.

Lancet (London, England) ·Vol. 356 ·No. 9246 ·2000-12-09 ·Pages 2013-4

Berger M

Abstract

暂无摘要

MeSH Terms
Carcinogens/adverse effects Diabetes Mellitus/drug therapy Humans Hypoglycemic Agents/adverse effects,therapeutic use Insulin/analogs & derivatives Mitogens/adverse effects
Chemicals
Carcinogens Hypoglycemic Agents Insulin Mitogens
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Berger M
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/S0140-6736(05)72989-5
Published
2000-12-09
Pages
2013-4
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
ErratumIn
-
CommentOn
PMID: 10981882
External Links
PubMed source DOI: 10.1016/S0140-6736(05)72989-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2